EULAR 2026 Daily Podcast Day 4a
From Rheumnow Podcast by Dr. Cush
June 7, 2026 · 33 min · Episode 1497
About this episode
This episode discusses the safety profile of bDMARDs and JAK inhibitors in axSpA and PsA, the need for CAR-T testing, and strategies to enhance Methotrexate efficacy.
MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsAHow Many CAR-Ts Do We Need to Test Drive?Making Methotrexate More Effective
People in this episode
Host: Dr. Cush
Topics covered
- bDMARDs
- JAK inhibitors
- axSpA
- PsA
- CAR-T therapy
- Methotrexate
Keywords
- bDMARDs
- JAK inhibitors
- axSpA
- PsA
- CAR-T
- Methotrexate
- safety profile
- treatment efficacy
Mentioned in this episode
Organizations: EULAR, axSpA, PsA
Products: bDMARDs, JAKis, CAR-Ts, Methotrexate
More episodes of Rheumnow Podcast
- RheumNow EULAR 2026 Rheumatology Round Up · June 12, 2026 · 56 min
- EULAR 2026 RA Topic Panel · June 11, 2026 · 54 min
- CAR-T Topic Panel EULAR 2026 · June 10, 2026 · 38 min
- EULAR 2026 PsA Update What's Changing in Psoriatic Arthritis Care? · June 9, 2026 · 49 min
- RA Topic Podcast compilation · June 8, 2026 · 1h 35m
- PsA Topic Podcast compilation · June 8, 2026 · 1h 37m
Explore listener stats, chart rankings, contacts and more on the Rheumnow Podcast podcast page.